How to manage steroid diabetes in the patient with cancer

J Support Oncol. 2006 Oct;4(9):479-83.

Authors

David S Oyer¹, Ajul Shah, Susan Bettenhausen

Affiliation

¹ Division of Endocrinology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. d-oyer@northwestern.edu

PMID: 17080737

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / adverse effects*
Blood Glucose / drug effects
Blood Glucose / metabolism
Dexamethasone / adverse effects
Diabetes Mellitus / chemically induced*
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / physiopathology
Humans
Hyperglycemia / chemically induced
Hyperglycemia / drug therapy
Hypoglycemic Agents / therapeutic use*
Insulin / therapeutic use
Insulin Resistance
Steroids / adverse effects*

Substances

Antineoplastic Agents
Blood Glucose
Hypoglycemic Agents
Insulin
Steroids
Dexamethasone